Mandate

Vinge advises Bergs Timber in connection with its in kind acquisition of Norvik’s timber operations in the Baltics and the United Kingdom.

June 28, 2018 Banking and Finance

Vinge has advised Bergs Timber AB (publ) (”Bergs Timber”) on legal matters in connection with its acquisition of Norvik hf’s (“Norvik”) timber operations in the Baltics and the United Kingdom.

The acquisition of Norvik’s timber operations in the Baltics and the United was approved by the extraordinary shareholders’ meeting in Bergs Timber held on May 14, 2018. The acquisition was made by an issue in kind where the contribution consisted of 170 million shares in Bergs Timber as well as a cash payment of SEK 270 million, amounting to a calculated value of approximately SEK 719 million as per April 17, 2018. The newly issued shares were admitted to trading on Nasdaq Stockholm, Small Cap, on June 7, 2018.

Through the acquisition, Bergs Timber will become a significant participant within the sawmill market, as its sawmill capacity increases from approximately 530,000 m³ per year to approximately 920,000 m³ per year. The acquisition will also increase Bergs Timber’s product processing and thus has the capacity of limiting Bergs Timber’s sensitivity to fluctuations in the economic cycle. The group’s raw materials base is also broadened while risks are spread as part of the production is based on costs in euro.

Vinge’s team primarily consisted of Jesper Schönbeck, Ulrich Ziche, Joel Wahlberg, Sabina Börjesson, Maria Dahlin, Johanna Wiberg, Ramin Baradaran, Pauline Lagerstrand, Boris Kotur, Vilhelm Rondahl and Fredric Reissmüller.
 

Related

Vinge advises Investor on its co-investment in the SEK 55 billion public offer for Fortnox led by EQT X

Vinge advises Investor AB (publ) (“Investor”) on its co-investment in the public offer for Fortnox AB (publ) (“Fortnox”) led by EQT X together with First Kraft AB (owned by Olof Hallrup), acting through Omega II AB (“Omega II”). Fortnox offers vital software infrastructure to small and medium-sized companies in Sweden with a track record of profitable growth.
July 22, 2025

Vinge advises Cantargia in connection with the sale of immunology program CAN10

Vinge advises Cantargia AB (publ) in connection with the sale of its early-clinical stage IL1RAP immunology program CAN10 to the Japanese healthcare company Otsuka Pharmaceutical.
July 21, 2025

Vinge has assisted PulPac in connection with it obtaining a €20 million financing from the European Investment Bank

Vinge has assisted Gothenburg-based sustainable packaging technology company PulPac in connection with it obtaining a €20 million (around 220 million Swedish kronor) financing from the European Investment Bank (EIB).
July 18, 2025